Changes in oxytocin content in rat brain during morphine withdrawal.
In this study the modification in the oxytocin content in different hypothalamic nuclei during morphine withdrawal was analysed. Male rats were implanted with placebo (naïve) or morphine (tolerant/dependent) pellets for 7 days. On day 7, groups of rats received an acute injection of saline s.c. (control) or naloxone (1 mg/kg s.c.) and were decapitated 30 min later. After administration of naloxone to tolerant rats (withdrawal) an increase in the oxytocin content in the paraventricular nucleus (PVN) and median eminence (ME) was found. No changes were found in the arcuate nucleus (AN) and supraoptic nucleus (SON). Present data demonstrate that administration of naloxone to tolerant rats alters the brain oxytocin system, which suggests that this peptide might contribute to the behavioural, emotional and neuroendocrine response to opioid.
Laorden
M L
ML
Department of Physiology and Pharmacology, University School of Medicine, Murcia, Spain. laorden@fcu.um.es
Milanés
M V
MV
Chapleur-Château
M
M
Burlet
A
A
D000818:Animals; D004343:Drug Implants; D008297:Male; D008473:Median Eminence / Q000378:metabolism; D009020:Morphine / Q000008:administration & dosage*; D009021:Morphine Dependence; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010121:Oxytocin / Q000378:metabolism*; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*
D004343:Drug Implants; D009292:Narcotic Antagonists; D009270:Naloxone; D010121:Oxytocin; D009020:Morphine